India remains engaged with the U.S. on Section 301 proceedings and for finalisation of a framework agreement

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic - Tariff differential gives Indian textiles, leather, gems, generic pharma a competitive edge over ASEAN/China [S2]. - Zero-duty for spices, tea, coffee, cashew, mango etc. helps agri-exports and small farmers [S2]. - Risk: residual 18% reciprocal tariff still erodes margins for MSMEs vs pre-Trump baseline [S2].

Geopolitical / Strategic - BTA dovetails with Quad and iCET cooperation; trade is a stabiliser amid China-related supply-chain realignment [S2]. - India avoids being lumped with adversarial tariff regimes (e.g., China at 35%) [S2].

Legal / WTO - Section 301 unilateral tariffs are WTO-inconsistent per DS152 (EC vs U.S., 1999) interpretation; India retains right to invoke DSU [S4]. - Domestic Indian safeguard via Customs Tariff Act, 1975 for any retaliatory action.

Administrative / Negotiation - Stakeholder consultations via USTR public hearings — Indian exporters/industry associations (FIEO, EPCs) must file by 22 June 2026 [S1]. - Carve-outs for textiles/apparel and Section 232 items demonstrate sectoral calibration [S1].

6. Recent Developments (last 12-18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources